Thermo Fisher Prices $3.2B in Senior Notes to Finance Life Tech Deal | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today announced that it has priced $3.2 billion worth of senior notes that will help fund a portion of its pending $13.6 billion acquisition of Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: CRISPR-based barcodes to trace cell lineages, and more.

The director of the National Institutes of Health Francis Collins sang the national anthem this week before a baseball game.

French researchers criticize unexpected government plan to cut research funding, ScienceInsider reports.

In Nature this week: genetic mechanism through which some cancers evade the immune system, and more.